Johnson & Johnson击败了2025年Q2收入估算,提高了全年指导水平,尽管机构销售量不大。 Johnson & Johnson beat Q2 2025 earnings estimates and raised full-year guidance, despite minor institutional selling.

2025年第二季度,Johnson & Johnson报告收入为每股2.77美元,粗略估计收入为0.09美元,收入为237.4亿美元,超过了预期。 In the second quarter of 2025, Johnson & Johnson reported earnings of $2.77 per share, beating estimates by $0.09, and revenue of $23.74 billion, surpassing expectations. 该公司将其2025财政年度收入指导提高到每股10.80至10.90美元,而分析师预计为10.58美元。 The company raised its FY 2025 earnings guidance to $10.80–10.90 per share, while analysts expect $10.58. 机构投资者的股份略有减少,Woodstock公司出售686个股份,Westmount Partners LLC公司减少了股份,而Merran金融集团LLC公司增加了4.8%。 Institutional investors reduced holdings slightly, with Woodstock Corp. selling 686 shares and Westmount Partners LLC reducing its stake, while Range Financial Group LLC increased its position by 4.8%. Johnson & Johnson的市场上限为427.46亿美元, 其季度红利为1.30美元, 收益率为2.9%。 Johnson & Johnson, with a market cap of $427.46 billion, pays a $1.30 quarterly dividend, yielding 2.9%. 股票的PE比率为18.98,贝塔比率为0.40。 The stock has a PE ratio of 18.98 and a beta of 0.40.